Puma Biotechnology, Inc. (PBYI) stock
PBYINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/3019% below fair value
$7.22+0.08 (+1.12%)
Close on Nov 18, 2026Market cap $372.70MP/E 13.9Yield –
Puma Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Puma Biotechnology's enterprise value was $326.11M on Nov 11, 2026, against $199.73M a year earlier. Over the last 5 years it ranged from $121.42M to $446.71M, with a median of $205.83M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $326.11M | +33.1% |
| 2025 | Dec 31, 2025 | $245.08M | +77.8% |
| 2024 | Dec 31, 2024 | $137.82M | -46.3% |
| 2023 | Dec 29, 2023 | $256.89M | +4.9% |
| 2022 | Dec 30, 2022 | $244.78M | +61.9% |
| 2021 | Dec 31, 2021 | $151.18M | -61.8% |
| 2020 | Dec 31, 2020 | $395.94M | +71.9% |
| 2019 | Dec 31, 2019 | $230.32M | -64.5% |
| 2018 | Dec 31, 2018 | $647.90M | -81.9% |
| 2017 | Dec 29, 2017 | $3.59B | +303.8% |
| 2016 | Dec 30, 2016 | $888.91M | -61.3% |
| 2015 | Dec 31, 2015 | $2.29B | -58.6% |
| 2014 | Dec 31, 2014 | $5.55B | +93.0% |
| 2013 | Dec 31, 2013 | $2.87B | +739.5% |
| 2012 | Dec 31, 2012 | $342.40M | – |
See a number that looks wrong?